NPI: 1043397292 · CLEVELAND, OH 44106 · General Acute Care Hospital · NPI assigned 11/01/2006
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 11/01/2006 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 231,001 | $11.60M |
| 2019 | 212,717 | $11.47M |
| 2020 | 165,849 | $12.33M |
| 2021 | 192,447 | $12.38M |
| 2022 | 182,630 | $11.71M |
| 2023 | 990,500 | $57.28M |
| 2024 | 758,387 | $40.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 1,896 | 1,185 | $14.60M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 89,345 | 80,982 | $13.03M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 98,130 | 85,631 | $12.78M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 67,712 | 60,780 | $10.43M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 71,776 | 62,589 | $9.24M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 55,703 | 47,270 | $8.09M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 32,383 | 29,657 | $4.54M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14,788 | 10,797 | $4.27M |
| 70450 | Computed tomography, head or brain; without contrast material | 13,277 | 10,826 | $3.81M |
| 99215 | Prolong outpt/office vis | 26,191 | 20,822 | $3.14M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 33,063 | 13,736 | $2.81M |
| 76819 | Fetal biophysical profile; without non-stress testing | 27,360 | 21,445 | $2.51M |
| 77386 | 5,947 | 453 | $2.18M | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 12,603 | 12,014 | $2.04M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2,540 | 2,452 | $1.78M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 12,464 | 6,383 | $1.75M |
| 59025 | Fetal non-stress test | 9,830 | 7,605 | $1.74M |
| D2930 | Prefabricated stainless steel crown - primary tooth | 3,239 | 934 | $1.70M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 10,081 | 6,199 | $1.58M |
| 41899 | Unlisted procedure, dentoalveolar structures | 1,468 | 1,245 | $1.45M |
| 76801 | 9,322 | 8,708 | $1.41M | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 5,031 | 2,773 | $1.32M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,130 | 6,452 | $1.31M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 12,028 | 7,136 | $1.29M |
| J9299 | Injection, nivolumab, 1 mg | 227 | 107 | $1.11M |
| G0378 | Hospital observation service, per hour | 17,310 | 7,437 | $1.05M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,722 | 2,575 | $853K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 9,430 | 4,162 | $815K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,080 | 2,609 | $808K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,267 | 3,242 | $759K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 37,643 | 27,921 | $753K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5,598 | 5,218 | $749K |
| 92557 | 9,574 | 9,184 | $718K | |
| 80053 | Comprehensive metabolic panel | 106,546 | 80,823 | $696K |
| 76813 | 5,605 | 5,322 | $663K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 1,193 | 500 | $656K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,261 | 1,695 | $639K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,953 | 2,535 | $596K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,822 | 3,524 | $580K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,078 | 1,777 | $576K |
| 36512 | 397 | 274 | $574K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 6,990 | 6,457 | $551K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 323 | 277 | $538K |
| 95886 | 1,894 | 1,707 | $519K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 512 | 426 | $509K |
| J0897 | Injection, denosumab, 1 mg | 449 | 323 | $505K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,883 | 3,165 | $503K |
| 92587 | 7,711 | 7,475 | $493K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 815 | 697 | $492K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,316 | 3,999 | $488K |
| 76820 | 6,144 | 3,634 | $481K | |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 896 | 253 | $473K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,999 | 2,566 | $472K |
| 95811 | 698 | 676 | $463K | |
| 77300 | 917 | 733 | $460K | |
| 77295 | 523 | 430 | $428K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 912 | 637 | $425K |
| 92550 | 5,168 | 4,938 | $414K | |
| 77334 | 1,156 | 746 | $409K | |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 82 | 36 | $401K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 676 | 471 | $400K |
| 95806 | 627 | 602 | $394K | |
| 77412 | 2,731 | 330 | $392K | |
| 82805 | 12,290 | 7,396 | $388K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,495 | 1,214 | $370K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 5,019 | 4,105 | $367K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 572 | 408 | $339K |
| J9022 | Injection, atezolizumab, 10 mg | 55 | 38 | $338K |
| 92567 | 8,564 | 8,319 | $336K | |
| 96367 | 3,457 | 2,056 | $334K | |
| 71046 | Radiologic examination, chest; 2 views | 23,875 | 20,215 | $320K |
| 76770 | 1,655 | 1,529 | $309K | |
| D7140 | Extraction, erupted tooth or exposed root | 1,247 | 508 | $307K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2,582 | 2,472 | $306K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 521 | 284 | $300K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 3,659 | 3,018 | $298K |
| 96416 | 1,133 | 530 | $298K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,449 | 2,005 | $296K |
| 96415 | 1,943 | 1,028 | $287K | |
| 97161 | 5,383 | 4,508 | $278K | |
| 95782 | 355 | 351 | $262K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 101 | 91 | $260K |
| 77336 | 2,378 | 991 | $258K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 5,173 | 4,646 | $257K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,859 | 10,855 | $257K |
| 86850 | 12,850 | 9,467 | $255K | |
| 77290 | 457 | 381 | $241K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 18,583 | 15,234 | $238K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2,434 | 395 | $233K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 1,070 | 793 | $221K |
| 70491 | 782 | 626 | $215K | |
| 88185 | 5,281 | 2,217 | $215K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 487 | 302 | $214K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 8,619 | 3,726 | $213K |
| 76642 | 2,387 | 2,050 | $212K | |
| 36430 | 1,671 | 923 | $203K | |
| 77301 | 244 | 201 | $199K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 206 | 166 | $195K |
| J9173 | Injection, durvalumab, 10 mg | 58 | 24 | $194K |
| 76830 | Ultrasound, transvaginal | 3,601 | 3,070 | $192K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 2,035 | 1,725 | $189K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1,013 | 865 | $178K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 9,138 | 7,269 | $177K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 135,133 | 104,656 | $171K |
| 70496 | 610 | 496 | $167K | |
| 93308 | 709 | 556 | $163K | |
| 36556 | 420 | 281 | $162K | |
| 95816 | 898 | 860 | $158K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 641 | 583 | $155K |
| 73610 | 4,273 | 3,408 | $151K | |
| 71250 | 1,648 | 1,467 | $149K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 41,590 | 31,917 | $148K |
| 93970 | 982 | 818 | $147K | |
| 84484 | 31,028 | 18,127 | $146K | |
| J2997 | Injection, alteplase recombinant, 1 mg | 875 | 202 | $145K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 51,459 | 40,128 | $145K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,124 | 1,007 | $144K |
| 73630 | 4,056 | 3,325 | $140K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,229 | 847 | $140K |
| 86900 | 12,985 | 9,557 | $140K | |
| 19083 | 156 | 121 | $137K | |
| 76536 | 1,179 | 1,091 | $135K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,108 | 618 | $135K |
| 97165 | 1,849 | 1,410 | $132K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 13,871 | 12,246 | $132K |
| 31575 | 689 | 609 | $127K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 833 | 498 | $122K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14,380 | 13,035 | $122K |
| 70498 | 876 | 699 | $117K | |
| 74183 | 531 | 473 | $114K | |
| 93971 | 1,436 | 1,182 | $114K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 410 | 297 | $111K |
| 90937 | 273 | 28 | $108K | |
| 88184 | 2,719 | 2,254 | $107K | |
| 93975 | 745 | 629 | $107K | |
| 0002A | 3,126 | 2,900 | $106K | |
| 77387 | 2,171 | 257 | $106K | |
| 0001A | 3,255 | 3,005 | $105K | |
| 92579 | 3,406 | 3,314 | $103K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12,477 | 10,117 | $101K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 747 | 657 | $100K |
| D1351 | Sealant - per tooth | 234 | 141 | $99K |
| J9306 | Injection, pertuzumab, 1 mg | 23 | 12 | $99K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 257 | 196 | $98K |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 415 | 147 | $94K |
| 01922 | 413 | 356 | $94K | |
| 72141 | 532 | 465 | $92K | |
| 80069 | 9,282 | 5,043 | $91K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 189 | 72 | $90K |
| 95924 | 246 | 217 | $89K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 220 | 143 | $89K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 174 | 91 | $88K |
| 71045 | Radiologic examination, chest; single view | 13,576 | 10,891 | $87K |
| 73030 | 3,457 | 2,731 | $85K | |
| 92585 | 364 | 354 | $85K | |
| 73560 | 1,911 | 1,536 | $83K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 44,766 | 37,084 | $83K |
| 90651 | 442 | 394 | $82K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 414 | 372 | $82K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,532 | 1,231 | $81K |
| 88341 | 1,523 | 561 | $80K | |
| 73130 | 3,544 | 2,729 | $80K | |
| 71271 | 517 | 483 | $80K | |
| 97016 | 2,029 | 782 | $78K | |
| 72197 | 300 | 250 | $75K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,194 | 4,676 | $75K |
| J1756 | Injection, iron sucrose, 1 mg | 3,090 | 1,248 | $73K |
| 85027 | 21,435 | 12,544 | $73K | |
| 97113 | 856 | 383 | $72K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 572 | 451 | $71K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 98 | 73 | $71K |
| 70486 | 2,081 | 1,679 | $71K | |
| 10060 | 412 | 337 | $70K | |
| 74018 | 1,410 | 1,132 | $69K | |
| 82947 | 35,420 | 17,070 | $69K | |
| 73562 | 1,676 | 1,388 | $69K | |
| 73502 | 2,139 | 1,785 | $68K | |
| 97116 | 1,761 | 930 | $68K | |
| 72110 | 1,207 | 1,084 | $68K | |
| 73110 | 2,412 | 1,931 | $64K | |
| 93017 | 807 | 653 | $64K | |
| 36415 | Collection of venous blood by venipuncture | 67,941 | 45,367 | $64K |
| 73590 | 2,661 | 2,090 | $64K | |
| 97162 | 1,184 | 1,020 | $63K | |
| 77280 | 552 | 417 | $63K | |
| 76982 | 1,520 | 1,326 | $62K | |
| 97535 | Self-care/home management training, each 15 minutes | 1,687 | 1,197 | $62K |
| 77338 | 248 | 202 | $61K | |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 202 | 104 | $60K |
| 90715 | 4,547 | 3,606 | $59K | |
| 94060 | 591 | 532 | $59K | |
| 88307 | 814 | 516 | $59K | |
| 12001 | 373 | 319 | $59K | |
| 90870 | 123 | 37 | $58K | |
| 73564 | 2,906 | 2,324 | $57K | |
| Q5117 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | 206 | 66 | $57K |
| 72125 | Computed tomography, cervical spine; without contrast material | 5,165 | 4,081 | $56K |
| 94618 | 673 | 614 | $56K | |
| 11982 | 264 | 228 | $56K | |
| 83605 | 21,691 | 13,743 | $54K | |
| 80320 | 2,715 | 2,157 | $51K | |
| 75574 | 191 | 139 | $51K | |
| 75561 | 181 | 151 | $50K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 398 | 231 | $49K |
| 58558 | 46 | 29 | $49K | |
| H2019 | Therapeutic behavioral services, per 15 minutes | 842 | 340 | $49K |
| 99152 | 3,567 | 2,650 | $49K | |
| 20610 | 384 | 286 | $47K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,951 | 1,815 | $47K |
| 74230 | 253 | 234 | $47K | |
| 96523 | 1,369 | 949 | $46K | |
| 74174 | 667 | 507 | $46K | |
| 76000 | 427 | 245 | $46K | |
| 86901 | 12,993 | 9,559 | $46K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3,379 | 3,189 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6,505 | 3,587 | $45K |
| 96376 | 9,550 | 4,517 | $45K | |
| 93296 | 2,043 | 1,921 | $45K | |
| 36591 | 3,806 | 2,332 | $45K | |
| 97802 | 475 | 439 | $45K | |
| 29581 | 439 | 150 | $44K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 34,440 | 23,317 | $44K |
| 73552 | 1,799 | 1,434 | $44K | |
| 77062 | 1,023 | 932 | $43K | |
| 92626 | 577 | 546 | $43K | |
| 93880 | 444 | 379 | $43K | |
| 82728 | 7,014 | 5,868 | $42K | |
| 58300 | 430 | 317 | $42K | |
| 81025 | 51,376 | 45,706 | $42K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14,367 | 13,026 | $41K |
| 72050 | 692 | 619 | $40K | |
| 83735 | 21,600 | 12,021 | $40K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 31 | 26 | $39K |
| 73140 | 633 | 560 | $38K | |
| 12002 | 263 | 206 | $38K | |
| 83021 | 4,434 | 3,173 | $37K | |
| 86920 | 1,871 | 821 | $37K | |
| 77080 | 588 | 547 | $37K | |
| 92526 | 604 | 375 | $35K | |
| 72100 | 875 | 757 | $35K | |
| 73090 | 1,501 | 1,175 | $34K | |
| 70544 | 232 | 183 | $34K | |
| 90791 | Psychiatric diagnostic evaluation | 181 | 168 | $34K |
| 93242 | 290 | 236 | $33K | |
| 72170 | 1,811 | 1,432 | $33K | |
| 83615 | 12,345 | 8,355 | $33K | |
| T1002 | Rn services, up to 15 minutes | 331 | 142 | $33K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8,323 | 6,487 | $33K |
| 93325 | 415 | 345 | $33K | |
| 92523 | 379 | 342 | $32K | |
| 72082 | 529 | 478 | $32K | |
| 77061 | 751 | 668 | $32K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 821 | 632 | $32K |
| 85610 | 26,517 | 16,312 | $32K | |
| 70487 | 119 | 86 | $32K | |
| 94726 | 612 | 556 | $32K | |
| J3490 | Unclassified drugs | 10,063 | 5,033 | $31K |
| 93922 | 451 | 404 | $31K | |
| 58301 | 282 | 233 | $31K | |
| 77072 | 311 | 283 | $31K | |
| 87536 | 1,886 | 1,652 | $31K | |
| 92551 | 283 | 277 | $31K | |
| 72131 | 1,010 | 808 | $31K | |
| 92604 | 836 | 766 | $30K | |
| 94729 | 755 | 690 | $30K | |
| 76818 | 321 | 250 | $30K | |
| 57454 | 91 | 74 | $30K | |
| 73700 | 254 | 203 | $30K | |
| 86780 | 5,653 | 4,582 | $30K | |
| 76981 | 455 | 401 | $30K | |
| 95885 | 91 | 83 | $30K | |
| 73221 | 139 | 124 | $29K | |
| 59430 | 252 | 235 | $29K | |
| 87081 | 2,890 | 2,503 | $29K | |
| 95923 | 233 | 206 | $28K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,031 | 9,017 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | 7,753 | 6,105 | $28K |
| 62323 | 99 | 85 | $28K | |
| 12011 | 185 | 145 | $28K | |
| 82330 | 17,582 | 11,157 | $27K | |
| 73080 | 1,147 | 929 | $26K | |
| 86141 | 2,581 | 2,189 | $26K | |
| J3535 | Drug administered through a metered dose inhaler | 1,046 | 474 | $26K |
| 38222 | 58 | 40 | $26K | |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 15 | 15 | $26K |
| 91200 | 209 | 177 | $25K | |
| 99153 | Mod sedat endo service >5yrs | 2,133 | 1,544 | $25K |
| 11045 | 73 | 52 | $25K | |
| 31579 | 87 | 78 | $24K | |
| D2934 | 41 | 13 | $24K | |
| 58661 | 18 | 12 | $24K | |
| 77470 | 46 | 38 | $23K | |
| D2330 | 49 | 27 | $23K | |
| 87800 | 5,137 | 4,107 | $23K | |
| 72128 | 815 | 650 | $23K | |
| 77065 | Tomosynthesis, mammo | 1,129 | 977 | $22K |
| 81001 | 31,568 | 27,326 | $22K | |
| 73070 | 520 | 425 | $22K | |
| 86922 | 929 | 462 | $22K | |
| J9070 | Cyclophosphamide, 100 mg | 201 | 57 | $21K |
| 76882 | 194 | 164 | $21K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 14 | 12 | $21K |
| 99406 | 1,082 | 925 | $21K | |
| 73060 | 1,104 | 849 | $20K | |
| 85007 | 2,907 | 1,489 | $20K | |
| 78816 | 27 | 27 | $20K | |
| 86808 | 1,036 | 937 | $20K | |
| 90686 | 1,542 | 1,141 | $20K | |
| J1453 | Injection, fosaprepitant, 1 mg | 1,641 | 856 | $19K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 165 | 158 | $19K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 344 | 282 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,319 | 2,028 | $19K |
| 93798 | 231 | 52 | $19K | |
| 76870 | 361 | 315 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,983 | 3,317 | $18K |
| 43235 | 65 | 45 | $18K | |
| 81003 | 24,641 | 20,846 | $18K | |
| 97166 | 288 | 211 | $17K | |
| 93350 | 75 | 68 | $17K | |
| 94010 | 535 | 442 | $17K | |
| 83880 | 6,374 | 4,758 | $17K | |
| 86902 | 1,487 | 657 | $17K | |
| J1815 | Injection, insulin, per 5 units | 1,136 | 392 | $17K |
| J1750 | Injection, iron dextran, 50 mg | 120 | 61 | $16K |
| 97010 | 469 | 226 | $16K | |
| 90837 | Psychotherapy, 53 minutes with patient | 130 | 79 | $16K |
| 85045 | 9,046 | 6,077 | $16K | |
| 84702 | 5,288 | 4,090 | $16K | |
| 72040 | 316 | 273 | $16K | |
| 72190 | 239 | 185 | $16K | |
| 82607 | 2,082 | 1,801 | $15K | |
| 93356 | 129 | 106 | $15K | |
| 92611 | 192 | 179 | $15K | |
| 96116 | 79 | 64 | $15K | |
| 73100 | 342 | 290 | $15K | |
| 80061 | Lipid panel | 2,695 | 2,332 | $15K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 3,861 | 1,862 | $15K |
| J9395 | Injection, fulvestrant, 25 mg | 157 | 116 | $15K |
| 77066 | Tomosynthesis, mammo | 1,183 | 1,067 | $14K |
| 96401 | 1,308 | 496 | $14K | |
| 88360 | 214 | 100 | $14K | |
| 95911 | 143 | 123 | $14K | |
| 0004A | 373 | 372 | $13K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 2,654 | 2,283 | $13K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4,975 | 4,197 | $13K |
| 93246 | 210 | 195 | $13K | |
| 96368 | 747 | 416 | $12K | |
| 36561 | 20 | 13 | $12K | |
| 83540 | 3,526 | 2,894 | $12K | |
| 87205 | 3,760 | 3,012 | $11K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 12,238 | 5,115 | $11K |
| 86832 | 287 | 239 | $11K | |
| 0072A | 283 | 283 | $11K | |
| 87631 | 58 | 56 | $11K | |
| 86140 | 2,047 | 1,530 | $11K | |
| 92652 | 214 | 209 | $11K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 5,841 | 1,665 | $11K |
| 74240 | 57 | 51 | $10K | |
| 87210 | 10,323 | 9,109 | $10K | |
| 99385 | 265 | 244 | $10K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 155 | 151 | $10K |
| 94660 | 89 | 39 | $10K | |
| 93321 | 222 | 177 | $10K | |
| 0012A | 502 | 445 | $10K | |
| 0071A | 259 | 257 | $10K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 56 | 40 | $10K |
| J9045 | Injection, carboplatin, 50 mg | 1,311 | 577 | $10K |
| 85730 | 6,492 | 4,653 | $10K | |
| C1760 | Closure device, vascular (implantable/insertable) | 332 | 244 | $10K |
| 71101 | 411 | 353 | $10K | |
| 88342 | 1,331 | 883 | $10K | |
| 83550 | 3,561 | 2,925 | $10K | |
| 31500 | 38 | 12 | $10K | |
| 95910 | 61 | 53 | $9K | |
| 85097 | 109 | 56 | $9K | |
| 70360 | 123 | 119 | $9K | |
| 82435 | 13,950 | 9,696 | $9K | |
| 77073 | 230 | 197 | $9K | |
| 84439 | 1,879 | 1,448 | $9K | |
| 82077 | 5,584 | 4,179 | $9K | |
| 29075 | 78 | 61 | $8K | |
| 80143 | 5,260 | 3,914 | $8K | |
| 0011A | 697 | 507 | $8K | |
| 72072 | 195 | 176 | $8K | |
| 86870 | 300 | 173 | $8K | |
| 0003A | 224 | 224 | $8K | |
| 97803 | 112 | 105 | $8K | |
| 82570 | 2,723 | 2,149 | $8K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 396 | 267 | $8K |
| 86923 | 241 | 132 | $8K | |
| 85018 | 10,527 | 6,800 | $8K | |
| 80346 | 516 | 438 | $8K | |
| 95913 | 58 | 51 | $8K | |
| 87070 | 1,655 | 1,166 | $8K | |
| 80361 | 741 | 612 | $8K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | 14 | $8K |
| 72081 | 108 | 97 | $7K | |
| 82533 | 1,389 | 1,008 | $7K | |
| 86833 | 280 | 237 | $7K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 322 | 120 | $7K |
| 72156 | 43 | 41 | $7K | |
| 86803 | 2,555 | 2,192 | $7K | |
| 73000 | 212 | 180 | $7K | |
| 82784 | 3,285 | 1,152 | $7K | |
| 84132 | 15,208 | 10,573 | $7K | |
| 97035 | 67 | 33 | $7K | |
| 99386 | 103 | 91 | $7K | |
| 82024 | 1,012 | 770 | $6K | |
| 83690 | 11,229 | 8,890 | $6K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 1,282 | 380 | $6K |
| 80076 | 1,060 | 824 | $6K | |
| C1776 | Joint device (implantable) | 60 | 42 | $6K |
| 58100 | 43 | 40 | $6K | |
| 73521 | 182 | 139 | $6K | |
| 80185 | 290 | 257 | $6K | |
| 86334 | 794 | 622 | $6K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 85 | 14 | $6K |
| 92610 | 88 | 82 | $6K | |
| 73620 | 154 | 116 | $6K | |
| 83970 | 449 | 326 | $6K | |
| 82378 | 1,211 | 826 | $6K | |
| 82248 | 1,758 | 1,273 | $5K | |
| 87186 | 2,542 | 1,911 | $5K | |
| 84295 | 14,127 | 9,852 | $5K | |
| 94762 | 98 | 58 | $5K | |
| J2800 | Injection, methocarbamol, up to 10 ml | 1,645 | 1,075 | $5K |
| 96402 | 1,046 | 734 | $5K | |
| 87075 | 2,573 | 1,532 | $5K | |
| 88237 | 77 | 38 | $5K | |
| 86706 | 1,069 | 861 | $5K | |
| 81379 | 14 | 13 | $5K | |
| 80197 | 906 | 373 | $5K | |
| 11981 | 26 | 13 | $5K | |
| 77293 | 49 | 40 | $5K | |
| 87340 | 1,342 | 1,110 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 25,583 | 17,328 | $5K |
| 76937 | 766 | 569 | $5K | |
| 87497 | 656 | 328 | $5K | |
| 82746 | 1,257 | 1,059 | $5K | |
| 72120 | 138 | 130 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,038 | 1,699 | $5K |
| 82550 | 2,196 | 1,384 | $5K | |
| 92524 | 69 | 61 | $5K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 38 | 15 | $5K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,302 | 1,642 | $5K |
| 95819 | 27 | 26 | $5K | |
| 84153 | 783 | 670 | $4K | |
| 87077 | 1,555 | 1,015 | $4K | |
| 99195 | 300 | 246 | $4K | |
| 74178 | 14 | 13 | $4K | |
| 87040 | 2,334 | 907 | $4K | |
| 99407 | 126 | 96 | $4K | |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 392 | 131 | $4K |
| 84100 | 4,100 | 2,849 | $4K | |
| 29065 | 40 | 31 | $4K | |
| 80349 | 530 | 416 | $4K | |
| 80179 | 5,214 | 3,911 | $4K | |
| 76885 | 33 | 28 | $4K | |
| 81382 | 30 | 13 | $4K | |
| 82962 | 3,583 | 2,683 | $4K | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 338 | 260 | $4K |
| 92950 | 48 | 28 | $4K | |
| 86318 | 447 | 385 | $4K | |
| 96158 | 44 | 27 | $4K | |
| 95909 | 44 | 38 | $4K | |
| J8501 | Aprepitant, oral, 5 mg | 214 | 129 | $4K |
| 84403 | 509 | 420 | $4K | |
| 84550 | 2,245 | 1,422 | $4K | |
| 87799 | 830 | 314 | $3K | |
| 87535 | 103 | 94 | $3K | |
| 88350 | 53 | 28 | $3K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,037 | 432 | $3K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,620 | 4,581 | $3K |
| 90677 | 95 | 92 | $3K | |
| 77370 | 20 | 14 | $3K | |
| J9206 | Injection, irinotecan, 20 mg | 291 | 126 | $3K |
| 80198 | 287 | 254 | $3K | |
| 0064A | 95 | 95 | $3K | |
| 73120 | 83 | 51 | $3K | |
| 86704 | 602 | 507 | $3K | |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | 171 | 89 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 30,365 | 23,711 | $3K |
| 86317 | 258 | 215 | $3K | |
| 88304 | 419 | 284 | $3K | |
| J2704 | Injection, propofol, 10 mg | 9,712 | 6,664 | $3K |
| 00300 | 312 | 219 | $3K | |
| 97014 | 68 | 26 | $3K | |
| 83883 | 502 | 189 | $3K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 21 | 21 | $3K |
| 82565 | 429 | 356 | $3K | |
| 76983 | 69 | 68 | $3K | |
| 90656 | 275 | 270 | $3K | |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 233 | 99 | $3K |
| 84165 | 1,196 | 910 | $2K | |
| 88112 | 309 | 211 | $2K | |
| 76942 | 457 | 350 | $2K | |
| 77001 | 365 | 251 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 389 | 377 | $2K |
| 96409 | 450 | 249 | $2K | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 42 | 26 | $2K |
| 00731 | 714 | 541 | $2K | |
| 84156 | 1,761 | 1,381 | $2K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 18 | 13 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 974 | 447 | $2K |
| 80365 | 536 | 422 | $2K | |
| A9270 | Non-covered item or service | 35,494 | 5,959 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 17,825 | 14,065 | $2K |
| J1953 | Injection, levetiracetam, 10 mg | 442 | 276 | $2K |
| 83521 | 969 | 705 | $2K | |
| 85384 | 1,565 | 1,054 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 110 | 109 | $2K |
| 76825 | 35 | 33 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 5,693 | 1,573 | $2K |
| 83010 | 695 | 473 | $2K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 81 | 33 | $2K |
| 86880 | 145 | 107 | $2K | |
| 70547 | 13 | 13 | $2K | |
| 87529 | 326 | 148 | $2K | |
| 85652 | 1,886 | 1,457 | $2K | |
| 88313 | 460 | 244 | $2K | |
| 73200 | 13 | 13 | $2K | |
| 87632 | 18 | 13 | $2K | |
| 81002 | 3,156 | 2,657 | $2K | |
| 72158 | 15 | 15 | $2K | |
| 88346 | 42 | 29 | $2K | |
| 82948 | 1,118 | 802 | $2K | |
| 73660 | 30 | 25 | $2K | |
| 85014 | 2,792 | 2,475 | $2K | |
| 90662 | 371 | 283 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,001 | 7,220 | $2K |
| 87522 | Neg quan hep c or qual rna | 183 | 140 | $2K |
| 80358 | 291 | 232 | $2K | |
| 76604 | 14 | 12 | $2K | |
| 85660 | 997 | 460 | $2K | |
| 73600 | 58 | 38 | $2K | |
| 84155 | 1,207 | 911 | $2K | |
| 85379 | 1,640 | 1,282 | $2K | |
| 82803 | 2,812 | 2,266 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 456 | 341 | $2K |
| 12013 | 18 | 13 | $2K | |
| 51798 | 288 | 251 | $2K | |
| 86038 | 222 | 202 | $2K | |
| 80354 | 294 | 234 | $2K | |
| 82043 | 529 | 481 | $2K | |
| 90688 | 119 | 93 | $2K | |
| 76827 | 34 | 32 | $1K | |
| 87101 | 72 | 71 | $1K | |
| 86481 | 75 | 68 | $1K | |
| 80373 | 263 | 210 | $1K | |
| J3411 | Injection, thiamine hcl, 100 mg | 911 | 362 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,972 | 1,924 | $1K |
| 80177 | 644 | 455 | $1K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12 | 12 | $1K |
| 90678 | 104 | 103 | $1K | |
| 99401 | 15 | 13 | $1K | |
| 82247 | 370 | 249 | $1K | |
| 86762 | 133 | 95 | $1K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 299 | 245 | $1K |
| C1769 | Guide wire | 1,352 | 964 | $1K |
| 96417 | 2,702 | 1,399 | $1K | |
| 83516 | 41 | 18 | $1K | |
| 72146 | 16 | 16 | $1K | |
| J7999 | Compounded drug, not otherwise classified | 1,556 | 1,115 | $1K |
| 88312 | 62 | 30 | $1K | |
| 76821 | 30 | 12 | $1K | |
| 96132 | 26 | 24 | $1K | |
| 89240 | 148 | 129 | $978.34 | |
| 82977 | 276 | 170 | $972.79 | |
| 87102 | 315 | 206 | $957.76 | |
| 00840 | 584 | 367 | $952.94 | |
| 97022 | 32 | 13 | $947.29 | |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | 249 | 185 | $928.92 |
| 80368 | 263 | 210 | $923.71 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 71 | 51 | $899.85 |
| 82375 | 622 | 490 | $893.19 | |
| 86825 | 35 | 28 | $881.19 | |
| 80329 | 705 | 249 | $871.58 | |
| 91300 | 6,866 | 6,102 | $861.80 | |
| 90670 | 92 | 91 | $858.43 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 1,851 | 1,383 | $825.48 |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,750 | 856 | $824.80 |
| 87467 | 158 | 105 | $823.09 | |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 80 | 41 | $809.67 |
| J2359 | Injection, olanzapine, 0.5 mg | 268 | 127 | $795.56 |
| 83050 | 599 | 474 | $790.71 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 5,470 | 2,580 | $787.45 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 24,337 | 16,297 | $783.44 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 930 | 781 | $774.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,072 | 2,801 | $760.59 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 483 | 339 | $741.39 |
| 84460 | 378 | 258 | $732.60 | |
| 84450 | 375 | 254 | $715.78 | |
| 80074 | 154 | 116 | $713.52 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 4,025 | 3,295 | $711.53 |
| 84075 | 371 | 248 | $692.14 | |
| 29125 | 253 | 188 | $687.41 | |
| 86592 | 115 | 80 | $659.91 | |
| 86301 | 139 | 99 | $653.96 | |
| 73523 | 22 | 16 | $652.94 | |
| 86364 | 26 | 26 | $652.89 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,033 | 734 | $648.76 |
| 86225 | 82 | 70 | $628.54 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 827 | 523 | $622.26 |
| 76776 | 20 | 13 | $621.96 | |
| 00142 | 595 | 427 | $615.65 | |
| 87506 | 12 | 12 | $611.68 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,412 | 622 | $608.24 |
| 0013A | 18 | 18 | $585.08 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 519 | 228 | $583.31 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 5,063 | 2,835 | $578.54 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 14 | 12 | $577.62 |
| 86235 | 84 | 45 | $570.56 | |
| 84445 | 19 | 19 | $570.23 | |
| 88311 | 176 | 122 | $567.33 | |
| 74220 | 13 | 12 | $566.50 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,131 | 642 | $559.83 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,046 | 2,613 | $557.43 |
| 00120 | 37 | 26 | $553.71 | |
| 72157 | 12 | 12 | $547.17 | |
| 86787 | 46 | 39 | $540.53 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,024 | 656 | $539.78 |
| 72070 | 13 | 12 | $536.71 | |
| 88142 | 39 | 31 | $528.60 | |
| 82150 | 206 | 151 | $519.23 | |
| 97032 | 18 | 12 | $512.57 | |
| 95012 | 12 | 12 | $501.65 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 12,355 | 8,815 | $500.37 |
| J2785 | Injection, regadenoson, 0.1 mg | 194 | 140 | $494.89 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 11,112 | 7,093 | $488.64 |
| 86580 | 14 | 14 | $488.01 | |
| 84145 | 59 | 40 | $475.90 | |
| G0008 | Administration of influenza virus vaccine | 391 | 331 | $475.67 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 970 | 663 | $473.61 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 16,490 | 11,816 | $463.39 |
| 86431 | 70 | 60 | $460.65 | |
| 85347 | 234 | 98 | $455.81 | |
| 86735 | 35 | 27 | $453.25 | |
| 86765 | 37 | 29 | $453.25 | |
| 80164 | 82 | 57 | $442.27 | |
| 87634 | 130 | 103 | $435.32 | |
| J3489 | Injection, zoledronic acid, 1 mg | 79 | 60 | $433.29 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,783 | 2,006 | $425.20 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 8,706 | 3,151 | $419.81 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 755 | 535 | $414.83 |
| 82010 | 364 | 255 | $401.40 | |
| 99417 | Prolong home eval add 15m | 686 | 579 | $398.23 |
| 87015 | 193 | 112 | $369.16 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 24 | 24 | $355.33 |
| 82232 | 51 | 40 | $348.74 | |
| 89051 | 167 | 113 | $338.82 | |
| 83002 | 32 | 28 | $337.16 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 1,057 | 546 | $335.72 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 361 | 239 | $334.66 |
| 88173 | 103 | 64 | $330.57 | |
| 82465 | 51 | 48 | $328.07 | |
| 87206 | 207 | 97 | $326.61 | |
| 86703 | 143 | 115 | $323.36 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 720 | 369 | $321.52 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,459 | 929 | $316.68 |
| 90633 | 31 | 31 | $307.55 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 290 | 158 | $296.09 |
| 83001 | 18 | 16 | $290.22 | |
| 92555 | 25 | 24 | $286.78 | |
| 90732 | 20 | 15 | $285.97 | |
| 86308 | 35 | 29 | $268.44 | |
| 90698 | 53 | 52 | $267.43 | |
| 51702 | 33 | 24 | $265.05 | |
| 84146 | 15 | 12 | $263.59 | |
| 87185 | 114 | 71 | $250.75 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 1,164 | 938 | $247.93 |
| 86300 | 136 | 106 | $243.69 | |
| 86304 | 21 | 15 | $240.91 | |
| 84540 | 79 | 51 | $237.91 | |
| J9190 | Injection, fluorouracil, 500 mg | 1,786 | 676 | $233.66 |
| 87449 | 48 | 39 | $230.18 | |
| J3590 | Unclassified biologics | 24 | 12 | $228.17 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,928 | 2,003 | $226.90 |
| 82668 | 74 | 64 | $215.81 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 560 | 390 | $211.92 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 88 | 79 | $208.48 |
| 82810 | 381 | 267 | $208.10 | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 285 | 181 | $196.38 |
| 84300 | 91 | 62 | $193.21 | |
| 82670 | 13 | 13 | $189.47 | |
| 93290 | 33 | 29 | $188.29 | |
| J3480 | Injection, potassium chloride, per 2 meq | 1,704 | 920 | $187.24 |
| 80202 | 21 | 12 | $186.27 | |
| 84133 | 76 | 53 | $186.19 | |
| J1940 | Injection, furosemide, up to 20 mg | 1,132 | 565 | $174.28 |
| 82436 | 47 | 37 | $162.13 | |
| A4217 | Sterile water/saline, 500 ml | 2,637 | 1,641 | $161.59 |
| C1780 | Lens, intraocular (new technology) | 327 | 237 | $158.66 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 143 | 114 | $155.59 |
| 36600 | 30 | 25 | $154.84 | |
| 76376 | 640 | 556 | $148.88 | |
| J7050 | Infusion, normal saline solution, 250 cc | 10,107 | 4,324 | $145.05 |
| 90696 | 14 | 14 | $132.90 | |
| 36410 | 19 | 13 | $123.80 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 1,463 | 686 | $121.40 |
| J1171 | Injection, hydromorphone, 0.1 mg | 680 | 364 | $116.73 |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 314 | 259 | $114.36 |
| 93299 | 14 | 12 | $114.02 | |
| 83935 | 35 | 24 | $111.58 | |
| 0753T | 368 | 243 | $109.12 | |
| J9267 | Injection, paclitaxel, 1 mg | 1,157 | 444 | $109.10 |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion | 44 | 25 | $95.68 |
| J2060 | Injection, lorazepam, 2 mg | 499 | 353 | $95.25 |
| J1790 | Injection, droperidol, up to 5 mg | 638 | 453 | $94.42 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 852 | 580 | $92.28 |
| 90710 | 16 | 15 | $91.86 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 79 | 67 | $90.17 |
| 76377 | 1,034 | 819 | $89.94 | |
| 86147 | 26 | 13 | $86.20 | |
| 94761 | 548 | 376 | $85.98 | |
| 82945 | 30 | 25 | $81.72 | |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 309 | 217 | $79.25 |
| 96411 | 1,144 | 677 | $73.87 | |
| 87116 | 41 | 25 | $73.24 | |
| 86593 | 18 | 13 | $71.85 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 94 | 14 | $66.65 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 278 | 267 | $63.81 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 184 | 80 | $63.65 |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 13 | 13 | $59.15 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 607 | 459 | $58.45 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 89 | 65 | $56.25 |
| 83718 | 45 | 42 | $55.67 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 285 | 103 | $55.58 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 624 | 374 | $53.05 |
| 86146 | 14 | 14 | $47.67 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,651 | 948 | $47.08 |
| 84436 | 16 | 14 | $46.29 | |
| 82140 | 54 | 40 | $45.01 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 31 | 25 | $44.46 |
| 84157 | 49 | 37 | $40.85 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 298 | 248 | $39.30 |
| 46600 | 160 | 125 | $38.09 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 821 | 636 | $37.49 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 448 | 246 | $32.80 |
| J0613 | Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg | 72 | 31 | $32.80 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 129 | 77 | $30.44 |
| A4648 | Tissue marker, implantable, any type, each | 372 | 284 | $30.09 |
| 86705 | 13 | 12 | $29.62 | |
| 29515 | 12 | 12 | $27.03 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 726 | 666 | $26.03 |
| 90648 | 14 | 14 | $21.03 | |
| 82950 | 15 | 13 | $17.64 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 779 | 520 | $16.63 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 276 | 255 | $14.97 |
| J0173 | Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg | 289 | 183 | $14.33 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 207 | 108 | $12.50 |
| 00400 | 177 | 105 | $12.40 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 149 | 129 | $12.28 |
| J0456 | Injection, azithromycin, 500 mg | 42 | 31 | $10.37 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 443 | 244 | $10.17 |
| 91301 | 1,240 | 991 | $6.65 | |
| 91307 | 624 | 601 | $5.94 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 470 | 343 | $4.96 |
| 96377 | 297 | 156 | $3.90 | |
| 36416 | 343 | 301 | $3.32 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 22 | 13 | $3.25 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 141 | 135 | $2.83 |
| 91305 | 132 | 123 | $1.22 | |
| 91306 | 86 | 86 | $0.77 | |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 24 | 24 | $0.07 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,079 | 752 | $0.00 |
| C1788 | Port, indwelling (implantable) | 20 | 13 | $0.00 |
| D1120 | Prophylaxis - child | 623 | 511 | $0.00 |
| C1752 | Catheter, hemodialysis/peritoneal, short-term | 112 | 62 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 494 | 435 | $0.00 |
| 00520 | 221 | 147 | $0.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 20 | 12 | $0.00 |
| 15853 | 43 | 42 | $0.00 | |
| 00811 | 91 | 67 | $0.00 | |
| Q0508 | Miscellaneous supply or accessory for use with an implanted ventricular assist device | 17 | 16 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 432 | 289 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 144 | 102 | $0.00 |
| 01810 | 24 | 24 | $0.00 | |
| 00145 | 20 | 15 | $0.00 | |
| 00140 | 23 | 16 | $0.00 | |
| 00940 | 18 | 12 | $0.00 | |
| 96159 | 19 | 12 | $0.00 | |
| C1729 | Catheter, drainage | 28 | 26 | $0.00 |
| 77003 | 19 | 12 | $0.00 | |
| 96138 | 13 | 12 | $0.00 | |
| 96133 | 13 | 12 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 63 | 60 | $0.00 |
| 00126 | 218 | 190 | $0.00 | |
| 80050 | General health panel | 74 | 54 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 12 | 12 | $0.00 |
| D0272 | Bitewings - two radiographic images | 267 | 222 | $0.00 |
| 00790 | 66 | 39 | $0.00 | |
| 00160 | 96 | 74 | $0.00 | |
| 00952 | 79 | 59 | $0.00 | |
| 00320 | 111 | 77 | $0.00 | |
| 94760 | 379 | 247 | $0.00 | |
| 01480 | 80 | 39 | $0.00 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 20 | 13 | $0.00 |
| C1819 | Surgical tissue localization and excision device (implantable) | 45 | 38 | $0.00 |
| J2305 | Injection, nitroglycerin, 5 mg | 13 | 12 | $0.00 |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study | 45 | 26 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 14 | 12 | $0.00 |
| C1727 | Catheter, balloon tissue dissector, non-vascular (insertable) | 20 | 12 | $0.00 |
| 96139 | 13 | 12 | $0.00 | |
| L8699 | Prosthetic implant, not otherwise specified | 13 | 12 | $0.00 |
| 00813 | 23 | 14 | $0.00 |